GC
AMPH icon

Globeflex Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Globeflex Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,210
Closed -$58.7K – 434
2024
Q3 		$58.7K Buy
1,210
+1,159
+2,273% +$50.9K 0.01% 402
2024
Q2 		$2.04K Sell
51
-2,305
-98% -$95.5K ﹤0.01% 450
2024
Q1 		$103K Hold
2,356
– – 0.01% 393
2023
Q4 		$146K Hold
2,356
– – 0.01% 350
2023
Q3 		$108K Hold
2,356
– – 0.01% 372
2023
Q2 		$135K Sell
2,356
-86,836
-97% -$3.85M 0.02% 351
2023
Q1 		$3.34M Buy
89,192
+23,070
+35% +$756K 0.41% 71
2022
Q4 		$1.85M Sell
66,122
-6,131
-8% -$178K 0.23% 109
2022
Q3 		$2.03M Hold
72,253
– – 0.35% 85
2022
Q2 		$2.51M Sell
72,253
-47
-0.1% -$1.68K 0.61% 33
2022
Q1 		$2.6M Sell
72,300
-46
-0.1% -$1.3K 0.53% 36
2021
Q4 		$1.69M Buy
72,346
+55,889
+340% +$1.14M 0.35% 73
2021
Q3 		$313K Hold
16,457
– – 0.07% 301
2021
Q2 		$332K Buy
+16,457
New +$310K 0.06% 340
2020
Q4 		– Sell
-21,594
Closed -$405K – 475
2020
Q3 		$405K Hold
21,594
– – 0.11% 287
2020
Q2 		$485K Buy
+21,594
New +$395K 0.12% 278
2017
Q2 		– Sell
-2,430
Closed -$35K – 414
2017
Q1 		$35K Sell
2,430
-48,256
-95% -$759K 0.01% 423
2016
Q4 		$934K Buy
50,686
+38,600
+319% +$751K 0.23% 170
2016
Q3 		$229K Hold
12,086
– – 0.06% 328
2016
Q2 		$195K Hold
12,086
– – 0.05% 331
2016
Q1 		$145K Hold
12,086
– – 0.04% 331
2015
Q4 		$172K Buy
+12,086
New +$160K 0.05% 319
2015
Q2 		– Sell
-48
Closed -$1K – 506
2015
Q1 		$1K Sell
48
-18
-27% -$241 ﹤0.01% 415
2014
Q4 		$1K Buy
+66
New +$719 ﹤0.01% 418

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Globeflex Capital's AMPH Position: Q4 2024 in Review

Globeflex Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 1,210 shares — an estimated $58.7K sold.

Globeflex Capital first reported a position in AMPH in Q4 2014 and held it in 24 quarters. The position peaked at $3.34M in Q1 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Globeflex Capital reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Globeflex Capital sold 1,210 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $58.7K.
  • Globeflex Capital first reported a position in Amphastar Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Globeflex Capital's Amphastar Pharmaceuticals position peaked at $3.34M in Q1 2023.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.